A recent study found that the maternal use of antibiotics during pregnancy appears to increase the risk of otitis media and the placement of ventilation tubes in the offspring, particularly when administered later in the pregnancy.
Treating children with acute otitis media with amoxicillin-clavulanate for 5 days is less effective than following standard 10-day treatment, according to a study in 520 such children who were aged 6 to 23 months.
As the healthcare profession continues to face challenges with antibiotic resistance, drugmakers are developing novel antibiotics that will be effective against some of the worst infections. One drugmaker submitted New Drug Applications (NDAs) for approval of IV and oral delafloxacin (Baxdela) to FDA.
For Contemporary Pediatrics, Dr Bobby Lazzara explains an abstract presented at the European Respiratory Society International Congress that examined whether early antibiotic exposure increases the risk of allergic rhinitis.
The protective effects of breastfeeding against infections and overweight are reduced or eliminated by antibiotic use early in life, according to a retrospective study in 226 5-year-old Finnish children, almost all of whom had been breastfed for at least 1 month.
FDA added new safety labeling changes for a class of antibiotics, fluoroquinolones (Levaquin, Cipro and other branded drugs), to enhance warnings about their association with disabling and potentially permanent side effects. Plus, the new labeling says that the drugs’ use should be limited in patients with less serious bacterial infections.